167 related articles for article (PubMed ID: 37416646)
1. CD7 protein plays a crucial role in T cell infiltration in tumors.
Sheng B; Zhang K; Tian S; Ma R; Li Z; Wu H; Wang T; Jiang L; You F; An G; Meng H; Yang L; Liu X
Heliyon; 2023 Jun; 9(6):e16961. PubMed ID: 37416646
[TBL] [Abstract][Full Text] [Related]
2. An Anti-CD7 Antibody-Drug Conjugate Target Showing Potent Antitumor Activity for T-Lymphoblastic Leukemia (T-ALL).
Wang S; Zhang R; Zhong K; Guo W; Tong A
Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254706
[TBL] [Abstract][Full Text] [Related]
3. CD7-deleted hematopoietic stem cells can restore immunity after CAR T cell therapy.
Kim MY; Cooper ML; Jacobs MT; Ritchey JK; Hollaway J; Fehniger TA; DiPersio JF
JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34423790
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of an anti-CD7-ricin A chain immunoconjugate in a novel murine model of human T-cell leukemia.
Fishwild DM; Aberle S; Bernhard SL; Kung AH
Cancer Res; 1992 Jun; 52(11):3056-62. PubMed ID: 1375534
[TBL] [Abstract][Full Text] [Related]
5. Tracing the expression of CD7 and other antigens during T- and myeloid-cell differentiation in the human fetal liver and thymus.
Bárcena A; Muench MO; Roncarolo MG; Spits H
Leuk Lymphoma; 1995 Mar; 17(1-2):1-11. PubMed ID: 7539656
[TBL] [Abstract][Full Text] [Related]
6. Autologous transplantation of bone marrow purged in vitro with anti-CD7-(WT1-) ricin A immunotoxin in T-cell lymphoblastic leukemia and lymphoma.
Preijers FW; De Witte T; Wessels JM; De Gast GC; Van Leeuwen E; Capel PJ; Haanen C
Blood; 1989 Aug; 74(3):1152-8. PubMed ID: 2473811
[TBL] [Abstract][Full Text] [Related]
7. CD7 and CD28 are required for murine CD4+CD25+ regulatory T cell homeostasis and prevention of thyroiditis.
Sempowski GD; Cross SJ; Heinly CS; Scearce RM; Haynes BF
J Immunol; 2004 Jan; 172(2):787-94. PubMed ID: 14707048
[TBL] [Abstract][Full Text] [Related]
8. Characterization of human CD7 transgenic mice.
Schanberg LE; Lee DM; Fleenor DE; Ware RE; Patel DD; Haynes BF; Kaufman RE
J Immunol; 1995 Sep; 155(5):2407-18. PubMed ID: 7544374
[TBL] [Abstract][Full Text] [Related]
9. Regulation of tumor growth by leukocyte-specific protein 1 in T cells.
Kwon R; Hong BK; Lee KG; Choi E; Sabbagh L; Cho CS; Lee N; Kim WU
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33020243
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic potential of anti-CD7 immunotoxin (WT1-ricin A) to purge ex vivo malignant T cells in bone marrow.
Preijers FW; De Witte T; Wessels JM; Meyerink JP; Haanen C; Capel PJ
Br J Haematol; 1989 Feb; 71(2):195-201. PubMed ID: 2784323
[TBL] [Abstract][Full Text] [Related]
11. CD3 gamma, CD3 delta, and CD3 zeta mRNA in adult human marrow hematopoietic progenitors correlates with surface CD2 and CD7 expression.
Long H; Gaffney P; Mortari F; Miller JS
Exp Hematol; 1996 Oct; 24(12):1402-8. PubMed ID: 8913286
[TBL] [Abstract][Full Text] [Related]
12. Early events in human T cell ontogeny. Phenotypic characterization and immunohistologic localization of T cell precursors in early human fetal tissues.
Haynes BF; Martin ME; Kay HH; Kurtzberg J
J Exp Med; 1988 Sep; 168(3):1061-80. PubMed ID: 2459287
[TBL] [Abstract][Full Text] [Related]
13. Twist2 regulates CD7 expression and galectin-1-induced apoptosis in mature T-cells.
Koh HS; Lee C; Lee KS; Park EJ; Seong RH; Hong S; Jeon SH
Mol Cells; 2009 Dec; 28(6):553-8. PubMed ID: 19937140
[TBL] [Abstract][Full Text] [Related]
14. Feasibility study of a novel preparation strategy for anti-CD7 CAR-T cells with a recombinant anti-CD7 blocking antibody.
Ye J; Jia Y; Tuhin IJ; Tan J; Monty MA; Xu N; Kang L; Li M; Lou X; Zhou M; Fang X; Shao J; Zhu H; Yan Z; Yu L
Mol Ther Oncolytics; 2022 Mar; 24():719-728. PubMed ID: 35317521
[TBL] [Abstract][Full Text] [Related]
15. CD7 expression in malignant pleural mesothelioma.
Hibi S; Kataoka Y; Fujita N; Okabe H; Yoshikawa K; Seto M; Ueda R; Imashuku S
Jpn J Cancer Res; 1992 Jul; 83(7):680-3. PubMed ID: 1381341
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of cytolytic CD8+ T cells in B16-melanoma and proliferation of mature T cells in TIS21-knockout mice after T cell receptor stimulation.
Ryu MS; Woo MY; Kwon D; Hong AE; Song KY; Park S; Lim IK
Exp Cell Res; 2014 Oct; 327(2):209-21. PubMed ID: 25088256
[TBL] [Abstract][Full Text] [Related]
17. Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma.
Zhang M; Chen D; Fu X; Meng H; Nan F; Sun Z; Yu H; Zhang L; Li L; Li X; Wang X; Wang M; You F; Li Z; Chang Y; Zhou Z; Yan J; Li J; Wu X; Wang Y; Wang Y; Xiang S; Chen Y; Pan G; Xu H; Zhang B; Yang L
Clin Cancer Res; 2022 Jul; 28(13):2830-2843. PubMed ID: 35435984
[TBL] [Abstract][Full Text] [Related]
18. In vivo anti-leukemic efficacy of anti-CD7-pokeweed antiviral protein immunotoxin against human T-lineage acute lymphoblastic leukemia/lymphoma in mice with severe combined immunodeficiency.
Gunther R; Chelstrom LM; Finnegan D; Tuel-Ahlgren L; Irvin JD; Myers DE; Uckun FM
Leukemia; 1993 Feb; 7(2):298-309. PubMed ID: 7678882
[TBL] [Abstract][Full Text] [Related]
19. Targeted gene disruption of murine CD7.
Bonilla FA; Kokron CM; Swinton P; Geha RS
Int Immunol; 1997 Dec; 9(12):1875-83. PubMed ID: 9466315
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of human acute T-cell leukemia in SCID mice using the anti-CD7-deglycosylated ricin A-chain immunotoxin DA7.
Jansen B; Vallera DA; Jaszcz WB; Nguyen D; Kersey JH
Cancer Res; 1992 Mar; 52(5):1314-21. PubMed ID: 1371092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
